INOVIO PHARMACEUTICALS, INC.
INOVIO PHARMACEUTICALS, INC. (INO): 7 pipeline candidates · 1 upcoming catalyst · ~5 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
5.2 months
D/E 7.20 · 0% dilution
Lead: Phase 3
7 candidates
1 upcoming, next in ~134d
N/A
A transparent, data-derived signal for INOVIO PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$92.6M
Cash
$26.3M
Quarterly Burn
$21.6M
Runway
5.2 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
98
Total value held
$60.1M
| Holder | Shares | Value |
|---|---|---|
| fmr llc | 9,339,614 | $16.3M |
| janus henderson group plc | 6,616,812 | $11.5M |
| vanguard capital management llc | 5,802,416 | $10.1M |
| d. e. shaw & co., inc. | 2,212,819 | $3.9M |
| adar1 capital management, llc | 1,470,108 | $2.6M |
| millennium management llc | 1,410,845 | $2.5M |
| adage capital partners gp, l.l.c. | 804,958 | $1.4M |
| geode capital management, llc | 801,504 | $1.4M |
| blackrock, inc. | 662,181 | $1.2M |
| renaissance technologies llc | 643,777 | $1.1M |
Showing top 10 of 98 institutional holders of INOVIO PHARMACEUTICALS, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in INOVIO PHARMACEUTICALS, INC.'s pipeline?
INOVIO PHARMACEUTICALS, INC. (INO) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is INOVIO PHARMACEUTICALS, INC.'s lead drug candidate?
INOVIO PHARMACEUTICALS, INC.'s most advanced tracked candidate is cemiplimab (Phase 1/Phase 2) for Glioblastoma.
What is INOVIO PHARMACEUTICALS, INC.'s next catalyst?
INOVIO PHARMACEUTICALS, INC.'s next tracked catalyst is a PDUFA event — "PDUFA Date: ino-3107" — expected October 30, 2026.
What is INOVIO PHARMACEUTICALS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, INOVIO PHARMACEUTICALS, INC. has approximately 5.2 months of cash runway.
What is INOVIO PHARMACEUTICALS, INC.'s market capitalization?
INOVIO PHARMACEUTICALS, INC.'s market capitalization is approximately $92.6M.
Get the full picture on INOVIO PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.